A study evaluates the risk for osteoporosis or osteopenia associated with 5-alpha reductase inhibitors in women with two ...

Show More From the Division of Urology, Washington University School of Medicine, St. Louis, MO. Prostate cancer remains a significant public health problem. The current approach with ...

Data on whether 5-ARIs increase the risk of prostate cancer-specific mortality have been mixed. Use of 5-alpha-reductase inhibitors (5-ARIs) does not increase the risk of dying from prostate cancer, ...

Asymptomatic men with a prostate-specific antigen (PSA) ≤ 3.0 ng/mL who are regularly screened with PSA or are anticipating undergoing annual PSA screening for early detection of prostate cancer may ...

Old man taking a pill New study is the largest to date assessing cardiovascular risks in patients taking alpha blockers. Men who take alpha blockers (ABs) rather than 5-alpha reductase inhibitors ...